Clinical Trial Update: Tumor Response in Hypofractionated Radiotherapy

View source ↗

Summary

This document provides an update on a clinical trial assessing tumor response to hypofractionated radiotherapy in neoplasms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Snippet

Sponsor: Peking University First Hospital | Conditions: Neoplasms | Status: UNKNOWN